Botanical species · safety record

Fraxinus excelsior

The EFSA Compendium of Botanicals holds 2 adverse-effect records for Fraxinus excelsior. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Fraxinus excelsior L.

0Constituent measurements
2Safety records
1Cited sources
32Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 32 licensed products naming Fraxinus excelsior as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Aged bark
  • Bark
  • Buds
  • Fruit
  • Leaf
  • Leaf/Leaves
  • Leaves and bark, in equal parts
  • Seed (fruit)

What the records describe

Plant parts

  • Seed2

Preparations

  • Solvent extraction2

Effect types

  • None2

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NoneSeedSolvent extractionRat (as animal)Acute toxicityResolve DOI
NoneSeedSolvent extractionHuman (as organism)Study with volunteersResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Flanagan, John., Meyer, Marjolaine., Angeles Pasamar, Maria., Ibarra, Alvin., Roller, Marc., Alvarez i Genoher, Nuria., Leiva, Sandra., Gomez-Garcia, Francisco., Alcaraz, Miguel., Martinez-Carrasco, Alberto., Vicente, Vicente. Safety evaluation and nutritional composition of a Fraxinus excelsior seed extract, FraxiPure (TM). FOOD AND CHEMICAL TOXICOLOGY, 2013, vol. 53, p. 10-17. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue